2:41
ASCOGU 25: Brad McGregor, MD, on TIVO in kidney cancer | Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
2:26
ASCOGU 25: Brad McGregor, MD Immunotherapy in bladder cancer | Dana-Farber Cancer Institute
2:05
ASCOGU25: Alicia Morgans, MD, MPH, COGCaP | Dana-Farber Cancer Institute
2:49
ASCOGU25: Atish Choudhury, MD, PhD | Dana-Farber Cancer Institute
2:31
Transatlantic Exchange in Oncology | Dana-Farber Cancer Institute
2:36
State Rep dedicated to constituents while in treatment for cancer | Dana-Farber Cancer Institute
3:10
Genomic mediators in melanoma: Rizwan Haq, MD, PhD | Dana-Farber Cancer Institute
2:43
Pharmacoequity in Oncology | Dana-Farber Cancer Institute
2:27
ASCOGU25: Toni Choueiri, MD, on LITESPARK003 | Dana-Farber Cancer Institute
1:54
ASCOGU25: Toni Choueiri MD., on Casdatifan | Dana-Farber Cancer Institute
1:26
ASCOGU25: Dr. Vincent Xu, MD, on KIM1 | Dana-Farber Cancer Institute
Exceptional responders in kidney cancer | Dana-Farber Cancer Institute
1:57
SABCS24: Ada Waks, MD, MARGOT study I Dana-Farber Cancer Institute
2:19
SABCS24: Judy Garber, MD, MPH I Dana-Farber Cancer Institute
2:06
SABCS24: Ann Partridge, MD PROs from the COMET study I Dana-Farber Cancer Institute
1:44
SABCS 24: Antonio Giordano, MD, PhD I Dana-Farber Cancer Institute
1:48
SABCS24: Jennifer Ligibel, MD, MPH | Dana-Farber Cancer Institute
2:22
ASH24: Katie Maurer, MD, PhD | Dana-Farber Cancer Institute
ASH24: Daniel DeAngelo, MD, PhD | Dana-Farber Cancer Institute
2:54
ASH24: Jennifer Brown, MD | Dana-Farber Cancer Institute
2:30
ASH24: Matthew Davids, MD, MMSC | Dana-Farber Cancer Institute
2:02
ASH24: Colleen Kelly, MD | Dana-Farber Cancer Institute
ASH24: Shai Shimony, MD, MPH & H. Moses Murdoch, MD | Dana-Farber Cancer Institute
3:29
ASH24: Jacqueline Garcia, MD | Dana-Farber Cancer Institute
Massachusetts breast health equity law | Dana-Farber Cancer Institute
2:28
Endometrial cancer research updates | Dana-Farber Cancer Institute
2:08
ISGC24: Betsy Lee, MD | Dana-Farber Cancer Institute
2:47
Thyroid cancer research in JAMA Oncology | Dana-Farber Cancer Institute
2:20
Toni Choueiri on casdatifan in kidney cancer: ENA24 | Dana-Farber Cancer Institute
Prostate cancer research advances | Dana-Farber Cancer Institute
4:24
Immunotherapy and gut bacteria | Dana-Farber Cancer Institute
SWI/SNF Inhibitors in POU2F3-positive small cell lung cancer | Dana-Farber Cancer Institute
2:29
Disparities in Pediatric Cancer Care: IGNITE Consortium | Dana-Farber Cancer Institute
1:34
ESMO24: Jennifer Ligibel, MD | Dana-Farber Cancer Institute
2:14
ESMO24: Jennifer Chan, MD, MPH CABINET Trial | Dana-Farber Cancer Institute
1:50
ESMO24: Marios Giannakis, MD, PhD | Dana-Farber Cancer Institute
1:21
ESMO24: Nancy Lin, MD Metastatic Brain Cancer | Dana-Farber Cancer Institute
2:12
ESMO24: Ann Partridge, MD, MPH, Breastfeeding after breast cancer | Dana-Farber Cancer Institute
2:53
ESMO24: Kimmie Ng, MD, MPH Vitamin D in Colorectal Cancer | Dana-Farber Cancer Institute
2:16
ESMO24: Toni Choueiri, MD, TiNivo in Kidney Cancer | Dana-Farber Cancer Institute
Kidney cancer research: Belzutifan versus everolimus | Dana-Farber Cancer Institute
2:52
Sex Bias in Kidney Cancer | Dana-Farber Cancer Institute
Excellence in Nursing: 5th Magnet Designation | Dana-Farber Cancer Institute
1:22
ATEMPT Breast Cancer Study | Dana-Farber Cancer Institute
3:11
CAR T cell therapy and infection prevention | Dana-Farber Cancer Institute
2:25
NUT Carcinoma : Jia Luo, MD | Dana-Farber Cancer Institute
1:41
Kidney Cancer CLEAR Trial biomarker analysis: Toni Choueiri, MD | Dana-Farber Cancer Institute
1:28
Kidney Cancer JAVELIN 101: Toni Choueiri, MD | Dana-Farber Cancer Institute
0:58
CNS Lymphoma: Lakshmi Nayak, MD | Dana-Farber Cancer Institute
2:33
SACI-IO HR+: Ana Garrido-Castro, MD | Dana-Farber Cancer Institute
Andrew Hantel, MD: Cancer Care and Greenhouse Gases | Dana-Farber Cancer Institute
International Medical Graduate Challenges: Narjust Florez, MD | Dana-Farber Cancer Institute
Artificial Intelligence and genomic data: Kenneth Kehl, MD, MPH| Dana-Farber Cancer Institute
ASCO Voices: Richard Leiter, MD, MA | Dana-Farber Cancer Institute
1:55
Xiao Wei, MD, MA on Prostate LuPSMA research at AUA24 | Dana-Farber Cancer Institute
2:34
Love Beyond Loss: A wife's journey after losing her husband to cancer | Dana-Farber Cancer Institute
2:38
Leukemia Research: New target for potential therapy | Dana-Farber Cancer Institute
2:46
Lobular Breast Cancer: Adventuring beyond diagnosis | Dana-Farber Cancer Institute
ONS Congress 2024: Jenny Spencer, RN, BSN | Dana-Farber Cancer Institute
2:00
ONS Congress 2024: Linda Ramsdell, MSN, FNP-BC | Dana-Farber Cancer Institute
ONS Congress 2024: Ludmila Svoboda, RN, MSN | Dana-Farber Cancer Institute
1:23
ONS Congress 2024: Jacqueline Tuskan, MSN, RN | Dana-Farber Cancer Institute
2:10
ONS Congress 2024: Marilyn Hammer, PhD, RN | Dana-Farber Cancer Institute
2:23
National Healthcare Decisions Day | Dana-Farber Cancer Institute
1:37
AACR24: Rebecca Porter, MD, Endometrial Cancer | Dana-Farber Cancer Institute
1:04
AACR24: Cami Christopher, MPH, Survivorship | Dana-Farber Cancer Institute
2:32
AACR24: Pasi Janne, MD, PhD, Lung Cancer | Dana-Farber Cancer Institute
2:48
AACR24: Robert Haddad, MD, Head and Neck | Dana-Farber Cancer Institute
Panos Konstantinopoulos, MD, PhD presents results from EPIK-O study | Dana-Farber Cancer Institute
Rachel Pozzar, PhD, RN on BOLSTER trial | Dana-Farber Cancer Institute
Young Mother Discusses Lynch Syndrome | Dana-Farber Cancer Institute
2:01
Miss America Madison Marsh raises pancreatic cancer awareness | Dana-Farber Cancer Institute
Cancer Equity and Accreditation Standard | Dana-Farber Cancer Institute
ASCO #GU24: Alok Tewari, MD, PhD | Dana-Farber Cancer Institute
2:35
ASCOGU24: Toni Choueiri, MD | Dana-Farber Cancer Institute
ASCOGU24: Xiao Wei, MD on LuPSMA | Dana-Farber Cancer Institute
ASCOGU24: Xiao Wei, MD on TPS244 | Dana-Farber Cancer Institute
ASCOGU24: Alicia Morgans, MD | Dana-Farber Cancer Institute
1:20
ASCOGU24: Himisha Beltran, MD | Dana-Farber Cancer Institute
ASCOGU24: Avina Rami | Dana-Farber Cancer Institute
0:59
ASCOGI24: Kimmie Ng, MD, MPH | Dana-Farber Cancer Institute
ASH23: Corey Cutler, MD, MPH, on AGAVE-201 | Dana-Farber Cancer Institute
3:25
SABCS23: Nolan Priedigkeit, MD, PhD on RNA fusions in breast cancer | Dana-Farber Caner Institute
SABCS23: Paolo Tarantino, MD, discusses RELIEVE study | Dana-Farber Cancer Institute
SABCS23: Heather Parsons, MD, MPH, discusses liquid biopsy | Dana-Farber Cancer Institute
SABCS23: Kate Dibble, PhD, discusses ovarian function suppression | Dana-Farber Cancer Institute
2:09
ASH23: Andrew Hantel, MD, discusses artificial intelligence | Dana-Farber Cancer Institute
2:39
ASH23: Paul Richardson, MD, discusses MEZI trial | Dana-Farber Cancer Institute
ASH23: Shai Shimony, MD, molecular ontogeny in AML | Dana-Farber Cancer Institute
1:58
ASH23: Elizabeth Lightbody, PhD, potential markers multiple myeloma | Dana-Farber Cancer Institute
1:52
ASH23: Corey Cutler, MD, MPH, on GVHD and stem cell transplant | Dana-Farber Cancer Institute
ASH23: Reid Merryman, MD, on ct-DNA & diffuse large B-cell lymphoma | Dana-Farber Cancer Institute
1:11
ASH23: Katie Maurer, MD, PhD, on immune system features and CAR-T | Dana-Farber Cancer Institute
1:01
ASH23: Shayna Sarosiek, MD, neuropathy in MGUS or Waldenstrom macroglobulinemia | Dana-Farber Cancer
1:43
ASH23: Jennifer Brown, MD, PhD, discusses ALPINE trial | Dana-Farber Cancer Institute
ASH23: Omar Nadeem, MD, discusses Immuno-PRISM trial | Dana-Farber Cancer Institute
ASH23: Andrew Hantel, MD, discusses clinical trial disparities | Dana-Farber Cancer Institute
CAR-T cost effectiveness study | Dana-Farber Cancer Institute
Neuroendocrine Tumors (NET) | Dana-Farber Cancer Institute
ESMO23: Brad McGregor, MD | Dana-Farber Cancer Institute
1:31
ESMO23: Toni Choueiri, MD LITESPARK-005 | Dana-Farber Cancer Institute
ESMO23: Toni Choueiri, MD LITESPARK-003 | Dana-Farber Cancer Institute
ESMO23: Robert Haddad, MD explains AIM-HN study | Dana-Farber Cancer Institute
ESMO23: Praful Ravi, MB BCHIR | Dana-Farber Cancer Institute
Stem cell transplant recipient meets donor | Dana-Farber Cancer Institute
Glioblastoma INSIGhT Trial | Dana-Farber Cancer Institute
Lung cancer research at World Lung Cancer Conference | Dana-Farber Cancer Institute
Negative studies | Dana-Farber Cancer Institute
Patient Helps After Colon Cancer Diagnosis | Dana Farber Cancer Institute
Artificial Intelligence to diagnose muscle wasting | Dana-Farber Cancer Institute
Living with kidney cancer | Dana-Farber Cancer Institute
1:45
Muscle wasting as a sign of pancreatic cancer | Dana-Farber Cancer Institute
Prostate cancer on the rise | Dana-Farber Cancer Institute
1:25
ASCO23: Patrick Wen, MD | Dana-Farber Cancer Institute
ASCO23: Sara Tolaney, MD, MPH | Dana-Farber Cancer Institute
ASCO23: Paolo Tarantino, MD | Dana-Farber Cancer Institute
ASCO23: Praful Ravi, MB BCHIR, MRCP | Dana-Farber Cancer Institute
ASCO23: Jia Luo, MD | Dana-Farber Cancer Institute
ASCO23: Glenn Hanna, MD | Dana-Farber Cancer Institute
1:51
ASCO23: Jennifer Ligibel, MD | Dana-Farber Cancer Institute
ASCO23: Toni Choueiri, MD | Dana-Farber Cancer Institute
Glioblastoma: Patient competes in Warrior Games | Dana-Farber Cancer Institute
1:24
ONS Congress: Terri Jabaley, PhD, RN | Dana-Farber Cancer Institute
ONS Congress 2023: Megan Corbett, MSN, RN | Dana-Farber Cancer Institute
ONS Congress 2023: Lauren McGovern, BSN, RN | Dana-Farber Cancer Institute
ONS Congress 2023: Rachel Pozzar, PhD, RN | Dana-Farber Cancer Institute
ONS Congress 2023: Linda Ramsdell, FNP-BC | Dana-Farber Cancer Institute
1:15
ONS Congress 2023: Paula Aguilera, BSN, RN | Dana-Farber Cancer Institute
2:07
Technology helping older patients with cancer | Dana-Farber Cancer Institute
AACR23: Harry Klein, PhD | Dana-Farber Cancer Institute
AACR23: James Lindsay, PhD | Dana-Farber Cancer Institute
1:30
AACR23: Ursula Matulonis, MD | Dana-Farber Cancer Institute
AACR23: Harsh Singh, MBBS | Dana-Farber Cancer Institute
Kidney Cancer Immunotherapy | Dana-Farber Cancer Institute
Screening catches colorectal cancer | Dana-Farber Cancer Institute
Prostate Cancer: Story of hope | Dana-Farber Cancer Institute
2:42
ASCO GU23 Paul Nguyen, MD: FORMULA-509 | Dana-Farber Cancer Institute
ASCO GU23 Toni Choueiri, MD: KEYNOTE-564 subgroup analysis | Dana-Farber Cancer Institute
ASCO GU23 Toni Choueiri, MD: CheckMate-9ER 3-year follow-up | Dana-Farber Cancer Institute
1:19
ASCO GU23 Triplet therapy in kidney cancer: Toni Choueiri, MD | Dana-Farber Cancer Institute
1:08
ASCO GU23 CheckMate-9ER Biomarker Analysis: Toni Choueiri, MD | Dana-Farber Cancer Institute
ASCO GU23 Treatment-free survival in kidney cancer | Dana-Farber Cancer Institute
ASCO GU 23 Penile Cancer Research | Dana-Farber Cancer Institute
What is Graft Versus Host Disease? | Dana-Farber Cancer Institute
1:33
COVID Booster and Cancer | Dana-Farber Cancer Institute
Multiple Myeloma precursor clinical trial helps patient | Dana-Farber Cancer Institute
Fertility and Cancer: A Story of Hope | Dana-Farber Cancer Institute
2:11
Colorectal cancer gene mutations | Dana-Farber Cancer Institute
Kidney cancer research supports immunotherapy | Dana-Farber Cancer Institute
Treating Insomnia in Black Women | Dana-Farber Cancer Institute
1:59
Esophageal Cancer: Get the facts | Dana-Farber Cancer Institute
Lynch Syndrome: Know your risk | Dana-Farber Cancer Institute
2:24
Breast Cancer: Rates rising in younger women | Dana-Farber Cancer Institute
3:21
Colorectal Cancer: Helping younger patients
Bladder Cancer: New study in preoperative treatment
FDA approval offers hope for prevention of acute graft-versus-host disease
First pediatric drug approval for prevention of graft-versus-host disease
0:51
Blood Cancer Research: Treatment for GVHD
Blood Cancer Research: Clinical trial helps younger patient
2:40
Blood Cancer: Higher rates of precursor in high-risk individuals
Kidney Cancer: New immunotherapy treatment after surgery
2:18
Stem Cell Transplant: Advances in graft v. host disease
Kidney Cancer: Drug shows activity in brain metastases
Rare Cancer: A father's journey with medullary kidney cancer
Gastric Cancer Awareness | Dana-Farber Cancer Institute
Colorectal cancer and the Black community | Dana-Farber Cancer Institute
2:17
Pancreatic cancer story of hope | Dana-Farber Cancer Institute
Esophageal cancer research advances | Dana-Farber Cancer Institute
2:13
Prostate Cancer: New treatment offers hope | Dana-Farber Cancer Institute
2:37
COVID-19: Clinical trials bounce back after significant disruption | Dana-Farber Cancer Institute
Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer Institute
Rare Brain Metastasis: Raising leptomeningeal disease awareness | Dana-Farber Cancer Institute
